ANAIRA Trademark

Trademark Overview

On Friday, January 22, 2010, a trademark application was filed for ANAIRA with the United States Patent and Trademark Office. The USPTO has given the ANAIRA trademark a serial number of 77918342. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2013. This trademark is owned by Glaxo Group Limited. The ANAIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
anaira

General Information

Serial Number77918342
Word MarkANAIRA
Filing DateFriday, January 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 28, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, September 3, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 2, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 25, 2013EXTENSION 5 GRANTED
Wednesday, January 23, 2013EXTENSION 5 FILED
Wednesday, January 23, 2013TEAS EXTENSION RECEIVED
Friday, August 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2012EXTENSION 4 GRANTED
Tuesday, July 31, 2012EXTENSION 4 FILED
Tuesday, July 31, 2012TEAS EXTENSION RECEIVED
Tuesday, January 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 21, 2012EXTENSION 3 GRANTED
Thursday, January 19, 2012EXTENSION 3 FILED
Thursday, January 19, 2012TEAS EXTENSION RECEIVED
Tuesday, August 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2011EXTENSION 2 GRANTED
Wednesday, July 20, 2011EXTENSION 2 FILED
Wednesday, July 20, 2011TEAS EXTENSION RECEIVED
Saturday, January 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 14, 2011EXTENSION 1 GRANTED
Thursday, December 16, 2010EXTENSION 1 FILED
Friday, January 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 16, 2010TEAS EXTENSION RECEIVED
Tuesday, August 3, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2010PUBLISHED FOR OPPOSITION
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 5, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 5, 2010ASSIGNED TO LIE
Friday, April 23, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 23, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 23, 2010LETTER OF SUSPENSION E-MAILED
Friday, April 23, 2010SUSPENSION LETTER WRITTEN
Wednesday, April 21, 2010ASSIGNED TO EXAMINER
Thursday, January 28, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 26, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

anaira pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic